Search results
Senators strike bipartisan tone on more pharma patent reforms
Endpoints News· 5 days agoThe issue of drug patent reform appears to have brought members from both sides of the aisle...
Cencora data breach exposes US patient info from 8 drug companies
BleepingComputer· 3 days agoCencora, formerly AmerisourceBergen, is a pharmaceutical services provider specializing in drug...
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever | The Motley Fool
The Motley Fool· 2 days agoThe key is to generate passive income. AbbVie (ABBV -0.76%) is one of the world's biggest...
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 4 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
3 S&P 500 Stocks That Have Proven Themselves Recession-Proof
InvestorPlace· 6 days agoSince 1928, there have been 25 bear markets, or declines in the S&P 500 of 20% or more, according to...
Senators Mull Ways to Stop Patent 'Abuse' by Pharma Companies
MedPage Today· 6 days ago"Too often the prices charged by Big Pharma do not reflect a scientific advancement," argued Sen....
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoTotal revenues in Q1 2024 increased to $37 million compared to $16 million in the same period last year. Gross margin in Q1 2024 increased to $17 million, by $40 million compared to the same period last year. Alvotech signed new commercialization
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
Zacks· 4 days agoTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...
What to know about biologics for Crohn's disease
Medical News Today· 4 days agoCrohn’s disease biologics are medications created using components of living organisms. Crohn’s disease (CD), along with ulcerative colitis, is one of...
Alvotech (NYSE:ALVO) Releases Quarterly Earnings Results, Misses Estimates By $0.81 EPS
ETF DAILY NEWS· 3 days agoAlvotech (NYSE:ALVO – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.89) earnings per share for the quarter, missing analysts’ consensus estimates ...